| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M509796200 |
| P8608 | Fatcat ID | release_iyuymn6irbdylpsai6porzt5iq |
| P698 | PubMed publication ID | 16216871 |
| P5875 | ResearchGate publication ID | 7548932 |
| P50 | author | Charles N Serhan | Q87981947 |
| P2093 | author name string | Wei Wang | |
| Pin-Lan Li | |||
| Amiram Ariel | |||
| Gabrielle Fredman | |||
| Katherine H Gotlinger | |||
| Song Hong | |||
| Wang-Xian Tang | |||
| P2860 | cites work | Regulation of Fas (CD95)-induced apoptosis by nuclear factor-KB and tumor necrosis factor- alpha in macrophages | Q23910429 |
| Discovery of a second 15S-lipoxygenase in humans | Q24336768 | ||
| A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease | Q24531755 | ||
| Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress | Q24561521 | ||
| Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
| Functional rafts in cell membranes | Q27860768 | ||
| Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
| Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells | Q28196391 | ||
| Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression | Q28199385 | ||
| Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation | Q28210028 | ||
| Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation | Q28348358 | ||
| A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense | Q28508815 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Mechanisms of action of docosahexaenoic acid in the nervous system | Q30666183 | ||
| Polyunsaturated fatty acids and rheumatoid arthritis | Q32064084 | ||
| Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins | Q33903345 | ||
| Cytokines in airway inflammation. | Q34001666 | ||
| A blast from the past: clearance of apoptotic cells regulates immune responses. | Q34162195 | ||
| Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies | Q34308645 | ||
| Polyunsaturated fatty acids and T-cell function: implications for the neonate | Q34449703 | ||
| Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration | Q34510295 | ||
| Cytokines and autoimmunity | Q34572227 | ||
| Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils | Q34621152 | ||
| Regulation of cytokine signaling and inflammation | Q34830660 | ||
| Anti-inflammatory lipid mediators and insights into the resolution of inflammation | Q34931955 | ||
| Inflammation and immune responses in atherosclerosis | Q34980819 | ||
| Chemokine receptors in inflammation: an overview | Q35048804 | ||
| Overview: apoptotic signaling pathways in the immune system | Q35129689 | ||
| Dietary n-3 polyunsaturated fatty acids promote activation-induced cell death in Th1-polarized murine CD4+ T-cells | Q35750014 | ||
| IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression | Q35866426 | ||
| Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Q36376065 | ||
| Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis | Q37174968 | ||
| Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation | Q40820913 | ||
| B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy | Q42675165 | ||
| Lipid mediator class switching during acute inflammation: signals in resolution. | Q43655799 | ||
| Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis | Q43901012 | ||
| The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis | Q44163974 | ||
| Recovery of brain docosahexaenoate leads to recovery of spatial task performance | Q44597255 | ||
| Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. | Q51588841 | ||
| Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. | Q52005840 | ||
| P433 | issue | 52 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| membrane raft | Q424178 | ||
| P304 | page(s) | 43079-43086 | |
| P577 | publication date | 2005-10-10 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering | |
| P478 | volume | 280 |
| Q28274315 | 12- and 15-lipoxygenases in adipose tissue inflammation |
| Q34189821 | 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γCounterregulated-Mediator of Allergic Airway Inflammation |
| Q35680221 | 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? |
| Q36696150 | 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation |
| Q37521297 | Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis |
| Q46656288 | Amyloid-Beta Peptide, Oxidative Stress and Inflammation in Alzheimer's Disease: Potential Neuroprotective Effects of Omega-3 Polyunsaturated Fatty Acids. |
| Q37071968 | Anti-inflammatory and proresolving lipid mediators |
| Q35633812 | Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression |
| Q49679435 | Bioactive Lipids and Chronic Inflammation: Managing the Fire Within |
| Q38237483 | Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers |
| Q37737608 | DHA metabolism: targeting the brain and lipoxygenation |
| Q28269550 | DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation |
| Q33631285 | Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease |
| Q57375098 | Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase |
| Q93345082 | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies |
| Q37191369 | Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders |
| Q31134484 | Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus |
| Q34330638 | Fatty acids, lipid mediators, and T-cell function |
| Q35552231 | Fish oil for the treatment of cardiovascular disease. |
| Q38046124 | Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis |
| Q37203391 | Impact of PUFA on early immune and fetal development |
| Q36867543 | Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation |
| Q35849963 | In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse |
| Q58728070 | Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control |
| Q37305409 | Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice |
| Q34465047 | Innate immunity is a key factor for the resolution of inflammation in asthma |
| Q37667919 | Lipid emulsions - Guidelines on Parenteral Nutrition, Chapter 6. |
| Q38118674 | Lipidomics of essential fatty acids and oxygenated metabolites |
| Q38089177 | Lipoxins, resolvins and protectins: new leads for the treatment of asthma |
| Q36981095 | Long-chain polyunsaturated fatty acids and the regulation of bone metabolism |
| Q52653114 | Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming. |
| Q55425775 | Macrophages, meta-inflammation, and immuno-metabolism. |
| Q36978388 | Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins |
| Q37909028 | Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation |
| Q90305563 | Multiplex profiling of inflammation-related bioactive lipid mediators in Toxocara canis- and Toxocara cati-induced neurotoxocarosis |
| Q34340306 | N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment |
| Q26849307 | N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence |
| Q45057004 | NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury |
| Q37181670 | Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology |
| Q33657934 | Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils |
| Q35928300 | New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation |
| Q34982051 | Novel anti-inflammatory--pro-resolving mediators and their receptors |
| Q37014326 | Novel biphasic role for lymphocytes revealed during resolving inflammation |
| Q33683210 | Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? |
| Q34522097 | Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins |
| Q35189668 | Novel proresolving aspirin-triggered DHA pathway |
| Q58571957 | Omega-3 PUFA vs. NSAIDs for Preventing Cardiac Inflammation |
| Q36572864 | Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury |
| Q35117457 | Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease |
| Q38194553 | Polyunsaturated Fatty Acid-derived lipid mediators and T cell function |
| Q34113615 | Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins |
| Q28716294 | Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation |
| Q37728979 | Pro-Resolving Molecules-New Approaches to Treat Sepsis? |
| Q30829097 | Pro-resolving lipid mediators are leads for resolution physiology |
| Q41864170 | Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses |
| Q34423365 | Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness |
| Q52725784 | Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury. |
| Q28387661 | Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome |
| Q33993206 | Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. |
| Q28652204 | Resolution of acute inflammation in the lung |
| Q26823724 | Resolution of inflammation in asthma |
| Q38054089 | Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications |
| Q37022898 | Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. |
| Q90240149 | Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA |
| Q29615694 | Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators |
| Q35332873 | Resolvins and protectins in inflammation resolution. |
| Q37447457 | Resolvins and protectins: mediating solutions to inflammation |
| Q37708842 | Resolvins and protectins: natural pharmacophores for resolution biology |
| Q37627490 | Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases |
| Q26766462 | Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease |
| Q34856260 | Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids |
| Q37168279 | Selective identification of specialized pro-resolving lipid mediators from their biosynthetic double di-oxygenation isomers |
| Q24658245 | Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1 |
| Q52583506 | Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. |
| Q88540273 | Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases |
| Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
| Q35098090 | Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution |
| Q42230042 | Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells |
| Q49585219 | Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. |
| Q36018475 | Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer |
| Q37525489 | Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator |
| Q30854633 | Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1. |
| Q36565510 | Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages |
| Q33384350 | Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators |
| Q28260186 | The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution |
| Q61053463 | The resolution of inflammation |
| Q36870120 | Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation |
| Q34516169 | Total synthesis of the anti-inflammatory and pro-resolving lipid mediator MaR1n-3 DPA utilizing an sp(3) -sp(3) Negishi cross-coupling reaction. |
| Q37724861 | Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions |
| Q34983954 | Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis |
| Q90341440 | Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis |
Search more.